The ARTS of third-generation mineralocorticoid receptor antagonists: achieving cardiovascular benefit with minimized renal side effects?

Mineralocorticoid receptor antagonists for therapy of coronary artery disease and related complications

(2013) Carolin Zwadlo et al.   CURRENT OPINION IN PHARMACOLOGY

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

(2013) Bertram Pitt et al.   EUROPEAN HEART JOURNAL

Discovery of BAY 94-8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases

(2012) Lars Bärfacker et al.   ChemMedChem

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

(2012) et al.   EUROPEAN HEART JOURNAL

Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice

(2012) F. Zannad et al.   EUROPEAN HEART JOURNAL

Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances

(2012) Paolo Galuppo et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors

(2012) Amy McCurley et al.   NATURE MEDICINE

Cardiomyocyte Mineralocorticoid Receptor Function Post Myocardial Infarction

(2012) Daniela Fraccarollo et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Deletion of Cardiomyocyte Mineralocorticoid Receptor Ameliorates Adverse Remodeling After Myocardial Infarction

(2011) Daniela Fraccarollo et al.   CIRCULATION

Determinants and Consequences of Renal Function Variations With Aldosterone Blocker Therapy in Heart Failure Patients After Myocardial Infarction

(2011) Patrick Rossignol et al.   CIRCULATION

Aldosterone, mineralocorticoid receptor, and heart failure

(2011) Smail Messaoudi et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Molecular pharmacology of the mineralocorticoid receptor: Prospects for novel therapeutics

(2011) Peter Kolkhof et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

(2010) Faiez Zannad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of Aldosterone Antagonists in Heart Failure

(2009) Nancy M. Albert   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION